| Bio-Path Holdings, Inc., (OTCBB: BPTH) ("Bio-Path"), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has entered into a services agreement with Los Angeles-based investor relations firm PondelWilkinson to assist the Company in implementing an investor and public relations program geared to the individual retail investment community. PondelWilkinson is experienced in fostering a long-term, credible foundation am...continued BPTH |
Thursday, March 29, 2012
Bio-Path Holdings Engages PondelWilkinson for Retail Investor Relations Program
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment